Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Cardiology

Journal Scan / Research · August 21, 2023

Feasibility and Safety of Class IC Antiarrhythmic Drug Use Among Patients With Varying Degrees of CAD

JACC: Clinical Electrophysiology


Additional Info

JACC: Clinical Electrophysiology
The Feasibility and Safety of Flecainide Use Among Patients With Varying Degrees of Coronary Disease
JACC Clin Electrophysiol 2023 Jul 01;9(7 Pt 2)1172-1180, S Kiani, MN Sayegh, R Ibrahim, NK Bhatia, FM Merchant, AD Shah, SB Westerman, DB De Lurgio, AM Patel, CM Thompkins, AR Leon, MS Lloyd, MF El-Chami

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading